Similar articles for PMID: 22554826

Year	Number of Results
1998	1
2001	2
2002	7
2003	3
2004	3
2005	6
2006	14
2007	10
2008	5
2009	6
2010	10
2011	15
2012	9
2013	2
2014	4
2015	6
2016	1
2017	2
2018	1
2019	3
2020	2
2021	2
2022	1
2024	0

1

Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase.

Bayorh M, Rollins-Hairston A, Adiyiah J, Lyn D, Eatman D. Bayorh M, et al. J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):353-9. doi: 10.1177/1470320312443911. Epub 2012 May 3. J Renin Angiotensin Aldosterone Syst. 2012. PMID: 22554826 Free PMC article.

2

Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4.

Bayorh MA, Rollins-Hairston A, Adiyiah J, Lyn D, Eatman D. Bayorh MA, et al. J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):195-201. doi: 10.1177/1470320310391330. Epub 2011 Feb 3. J Renin Angiotensin Aldosterone Syst. 2011. PMID: 21292834 Free PMC article.

3

Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.

Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Lacolley P, et al. Circulation. 2002 Nov 26;106(22):2848-53. doi: 10.1161/01.cir.0000039328.33137.6c. Circulation. 2002. PMID: 12451013

4

Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.

Bayorh MA, Mann G, Walton M, Eatman D. Bayorh MA, et al. Clin Exp Hypertens. 2006 Feb;28(2):121-32. doi: 10.1080/10641960500468276. Clin Exp Hypertens. 2006. PMID: 16546838

5

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.

Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E. Rocha R, et al. Endocrinology. 2002 Dec;143(12):4828-36. doi: 10.1210/en.2002-220120. Endocrinology. 2002. PMID: 12446610

6

Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.

Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T. Nagase M, et al. Hypertension. 2006 Jun;47(6):1084-93. doi: 10.1161/01.HYP.0000222003.28517.99. Epub 2006 Apr 24. Hypertension. 2006. PMID: 16636193

7

Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone.

Nehme J, Mercier N, Labat C, Benetos A, Safar ME, Delcayre C, Lacolley P. Nehme J, et al. J Renin Angiotensin Aldosterone Syst. 2006 Mar;7(1):31-9. doi: 10.3317/jraas.2006.004. J Renin Angiotensin Aldosterone Syst. 2006. PMID: 17083071 Free article.

8

Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.

Zhou X, Crook MF, Sharif-Rodriguez W, Zhu Y, Ruben Z, Pan Y, Urosevic-Price O, Wang L, Flattery AM, Forrest G, Szeto D, Zhao H, Roy S, Forrest MJ. Zhou X, et al. Clin Exp Hypertens. 2011;33(8):538-47. doi: 10.3109/10641963.2011.566956. Epub 2011 Sep 27. Clin Exp Hypertens. 2011. PMID: 21950654 Free PMC article.

9

Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.

Pojoga LH, Adamová Z, Kumar A, Stennett AK, Romero JR, Adler GK, Williams GH, Khalil RA. Pojoga LH, et al. Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1776-88. doi: 10.1152/ajpheart.00661.2009. Epub 2010 Apr 2. Am J Physiol Heart Circ Physiol. 2010. PMID: 20363891 Free PMC article.

10

Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney.

Eatman D, Layas MF, Bayorh MA. Eatman D, et al. Kidney Blood Press Res. 2010;33(3):167-73. doi: 10.1159/000316700. Epub 2010 Jun 23. Kidney Blood Press Res. 2010. PMID: 20571278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year